Laid off from Pfizer.

Previous rounds

Pfizer layoff history

Pfizer announces money, not headcount. Its second-quarter results release on August 4, 2026 added about $1.0 billion of expected net cost savings to the Realigning Our Cost Base Program and about $1.5 billion to the Manufacturing Optimization Program, carried both out to 2029, and set roughly $2.0 billion and $4.0 billion of one-time costs against them. Severance is named inside both of those cost lines. What the release didn't give was a number of jobs or a list of places, and a company spokesperson declined to say how the severance would be paid out or whether any jobs would be affected.

The size of the change shows up in headcount instead. Pfizer's annual reports put its worldwide workforce at about 88,000 people at the end of 2023, Seagen colleagues included, and about 75,000 two years later. That's roughly 13,000 fewer by subtraction across the two filings, a spread that absorbs quitting and divestitures as well as layoffs. The same filings price what the reduction cost to run. Employee termination charges came to $684 million in 2025, after $1.152 billion in 2024 and $1.622 billion in 2023, and the cost realignment program has run up $4.9 billion of its expected $7.3 billion.

The severance trail is unusually visible for a company that publishes no formula for most of its staff. Pfizer's accrual for employee termination costs opened 2025 at $2.046 billion, took on $684 million more, paid out $947 million, and closed the year at $1.783 billion. That closing figure was Pfizer's recorded liability for employee termination costs at the end of 2025, an accounting accrual rather than a fund with names attached to it. The same note records something quieter. Its 2025 and 2024 termination charges included revisions to previously booked severance accruals, which the filing attributes in large part to higher-than-expected voluntary attrition. Enough people left on their own that the company revised down what it had booked for severance.

For one person the record narrows fast. The only severance formula Pfizer publishes sits in its 2026 proxy statement, covering named executive officers and other executive leadership team members whose positions are eliminated. For them, cash severance is the greater of one times pay, meaning base salary plus target annual incentive, or 13 weeks' pay plus three weeks for each full year of service, up to 104 weeks. Nothing on record sets out an equivalent for anyone below that tier, which leaves the separation agreement in front of you as the document that actually fixes your terms. Read what it says about timing before you sign anything, and if it names a deadline, work to that date rather than to the program calendar behind it.

The cuts themselves have landed one site at a time. Our tracker holds 24 Pfizer filings all-time and 2 covering 156 jobs since the start of 2025. The larger of the two is 100 jobs at Bothell, Washington beginning August 25, 2025, at the site that had been Seagen's headquarters, and Pharmaceutical Executive reported the same notice. BioSpace reported 56 people cut from San Diego that April, the month our tracker records a 56-job California filing. A year earlier a North Carolina notice covered 210 workers, 150 at Sanford and 60 at Rocky Mount, which a spokesperson attributed to a failed gene therapy trial and a discontinued product line. Our tracker holds nothing for 2026, which is worth knowing if you're waiting to see your own site named.

Reporting on previous Pfizer layoff rounds

• August 2025, 100 jobs at Bothell, Washington · A WARN notice covered 100 jobs at the Bothell site, which had been Seagen's headquarters, with layoffs beginning August 25, 2025, and Pharmaceutical Executive reported the same notice. A spokesperson said the effort was part of a push to improve "R&D productivity and efficiency with a sharpened focus on opportunities" and to simplify "the way it works through digital enablement and automation".

• April 2025, 56 jobs in California · BioSpace reported 56 employees cut from Pfizer's San Diego site in April 2025, the same month our tracker records a 56-job California filing. The tracker row carries no city of its own.

• July 2024, 210 jobs at two North Carolina sites · A state WARN notice covered 210 workers, 150 at Sanford and 60 at Rocky Mount. A company spokesperson tied the Sanford cuts to a Phase 3 trial failure that June for Pfizer's experimental Duchenne muscular dystrophy gene therapy, and said Rocky Mount was shutting select sterile injectables lines as it discontinued its large volume solutions business.

How Pfizer's layoffs compare to other companies

Pfizer itemizes its restructuring costs down to the million, $875 million of charges under the manufacturing program alone, while saying nothing about what any individual receives. The one severance formula it does publish sits in the proxy statement and covers the executive leadership team.

What to do after being laid off from Pfizer

1. File for unemployment in the state where you worked. Benefits run from your filing date, and severance usually doesn't block you. Pfizer's biggest hubs: California, North Carolina, Washington. Somewhere else? Every state is here.
2. Apply for financial and hardship assistance. Unemployment supplements income, but food benefits, health coverage and utility help are often available as well. Here's some of what Pfizer's hub states run: California, North Carolina, Washington, and every other state is here.
3. Mind the health insurance window. Losing coverage opens a 60-day special enrollment period, and an ACA plan usually beats unsubsidized COBRA. Compare your options before the employer coverage lapses, and read how the COBRA clocks run if you are weighing it seriously.
4. Get your real runway number. Severance plus savings divided by reality. The calculator takes five minutes.
5. Know which clocks are already running. Severance review windows, COBRA election, visa grace periods, and 401(k) rollovers all run on federal deadlines that started at termination. All five deadlines are here.